WIT is proud to feature individuals who contribute to WIT’s mission of: (1) Advancing and inspiring women transplant professionals (Pillar 1), (2) Championing issues of sex and gender in transplantation (Pillar 2), and (3) Advocacy to address sex and gender-related disparities in transplantation (Pillar 3). Learn more about clinicians, researchers, and patients who shed light on disparities and try to overcome them to improve patient outcomes.
Dr Brenda Maria Rosales is a Post-doctoral Research Fellow at The University of Sydney. PhD graduate in 2021, she was awarded the Sanofi Women in Transplantation Research Fellowship Grant for Research in Gender and Sex in Transplantation in 2022. She has received TTS Young Investigator and TSANZ Early Career Researcher awards.
Cancer mortality in kidney transplant recipients differs by age and sex. This indicates possible systemic biases in the delivery of cancer care. There is a need to evaluate current clinical practice to identify points of sex and gender inequity in and healthcare delivery for cancer management in kidney transplant recipients.
Cancer disproportionally impacts kidney transplant recipients, but it affects men and women differently. Male kidney transplant recipients have higher absolute cancer incidence and mortality compared to females; however, female kidney transplant recipients experience greater excess cancer death(1,2). Sex and gender differences have also been described in access to healthcare and consequently there has been an increase of gender-based health plans, particularly in cardiovascular disease(3,4).
Investigation of how sex impact access to cancer care may identify systemic biases in cancer care delivery to kidney transplant recipients.
Using existing health data and survey of kidney transplant recipients, our work asks, how do sex and gender impact access and equity in cancer care for kidney transplant recipients?
What does the data say?
We will use evidence integration and population data to investigate the impact of sex on access to cancer screening, efficacy of cancer treatment and, relative survival in kidney transplant recipients with cancer.
What do our patients say?
We will explore gender-based experiences of cancer care in kidney transplant recipients using focus-group interviews and online preferences surveys to identify barriers in access and elicit patient preferences for treatment.
What does it mean for our patients?
Our work will provide a better understanding of the varied needs of males, females and people of nonbinary gender and, how current cancer prevention and treatment strategies differ by sex & gender. Our findings will inform strategies to deliver more equitable cancer care for kidney transplant recipients to balance its benefits and harms.
Women in Transplantation encourage all members to submit abstracts and manuscripts to the inaugural Frontiers in Transplantation "Women in Immunosuppression” series of article collections.
Abstract Submission Deadline: 07 November 2023
Manuscript Submission Deadline: 11 March 2024
Who can take part?
• Women over 18 years of age
What will be involved in participating?
• Global interviews are taking place
• Held at a time that suits you
• Face-to-face via telephone or video conference
What will be asked?
How accessible your treatment has been and some of the hurdles you may have faced living with your transplanted kidney.
If you are interested in participating, please contact:
Research Fellow and Transplant recipient